Document is current

Any future updates will be listed below

Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M

Crossref DOI link: https://doi.org/10.1038/s41598-021-97248-w

Published Online: 2021-08-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark